Doxorubicin-Based Hybrid Compounds as Potential Anticancer Agents: A Review
The scarcity of novel and effective therapeutics for the treatment of cancer is a pressing and alarming issue that needs to be prioritized. The number of cancer cases and deaths are increasing at a rapid rate worldwide. Doxorubicin, an anticancer agent, is currently used to treat several types of ca...
Main Authors: | Sijongesonke Peter, Sibusiso Alven, Rejoice Bethusile Maseko, Blessing Atim Aderibigbe |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/14/4478 |
Similar Items
-
Chlorambucil-Bearing Hybrid Molecules in the Development of Potential Anticancer Agents
by: Sijongesonke Peter, et al.
Published: (2023-09-01) -
The Therapeutic Efficacy of Dendrimer and Micelle Formulations for Breast Cancer Treatment
by: Sibusiso Alven, et al.
Published: (2020-12-01) -
Efficacy of Polymer-Based Nanocarriers for Co-Delivery of Curcumin and Selected Anticancer Drugs
by: Sibusiso Alven, et al.
Published: (2020-08-01) -
Combination Therapy Strategies for the Treatment of Malaria
by: Sibusiso Alven, et al.
Published: (2019-10-01) -
Artemisinin and Derivatives-Based Hybrid Compounds: Promising Therapeutics for the Treatment of Cancer and Malaria
by: Sijongesonke Peter, et al.
Published: (2021-12-01)